1. Home
  2. CAE vs AMRX Comparison

CAE vs AMRX Comparison

Compare CAE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

N/A

Current Price

$27.65

Market Cap

7.7B

Sector

N/A

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$21.49

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAE
AMRX
Founded
1947
2002
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
6.4B
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
CAE
AMRX
Price
$27.65
$21.49
Analyst Decision
Buy
Strong Buy
Analyst Count
15
7
Target Price
★ $32.75
$24.29
AVG Volume (30 Days)
444.7K
★ 3.7M
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 157.89
EPS
N/A
★ 0.29
Revenue
N/A
N/A
Revenue This Year
$1.99
$6.38
Revenue Next Year
$0.82
$9.21
P/E Ratio
★ $35.13
$57.46
Revenue Growth
N/A
N/A
52 Week Low
$22.76
$11.39
52 Week High
$34.24
$21.68

Technical Indicators

Market Signals
Indicator
CAE
AMRX
Relative Strength Index (RSI) 71.87 61.46
Support Level $24.93 $16.59
Resistance Level $28.55 N/A
Average True Range (ATR) 0.84 0.83
MACD 0.21 -0.01
Stochastic Oscillator 95.77 93.21

Price Performance

Historical Comparison
CAE
AMRX

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: i) Civil Aviation: Provides comprehensive training solutions for flight, cabin, maintenance, ground personnel and air traffic controllers in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as airline operations digital solutions; and ii) Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: